NA Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

North America Molecular Point of Care Testing (using NAAT) Market By Product (Instruments and Consumables & Reagents), Indication (Respiratory Infections Testing, Sexually Transmitted Infection (STI) Testing, Gastrointestinal Tract Infections Testing, and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (U.S. and Canada) – Industry Trends and Forecast to 2028

Market Definition:
POCT (Point of Care Testing) is characterized as testing which can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. POCT devices now entering clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm. These instruments are essentially used in molecularly detecting various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques that allow the identification of pathogenic organisms by detecting their DNA or RNA.

Market Segmentation:
North America molecular point of care testing (using NAAT) market is segmented into five notable segments based on the product, indication, end user, mode of testing, and distribution channel.

• On the basis of product, the North America molecular point of care testing (using NAAT) market is segmented into instruments and consumables and reagents
• On the basis of indication, the North America molecular point of care testing (using NAAT) market is segmented into sexually transmitted infection (STI) testing, respiratory infection testing, gastrointestinal tract infection testing, and others
• On the basis of end user, the North America molecular point of care testing (using NAAT) market is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, and others
• On the basis of mode of testing, the North America molecular point of care testing (using NAAT) market is segmented into prescription-based testing and OTC testing
• On the basis of distribution channel, the North America molecular point of care testing (using NAAT) market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy

Market Players

The key market players for North America molecular point of care testing (using NAAT) market are listed below:

• SD Biosensor, Inc.
• Abbott
• F.Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc
• binx Health, Inc.
• Lucira
• Meridian Bioscience
• Quantumdx Group Ltd.
• BD
• Biomérieux Sa
• Qiagen
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Sekisui Diagnostic
• Randox Laboratories Ltd.
• GenMark Diagnostics
• Seegene Inc. 
• Grifols S.A.
• Wondfo
• Oxford Nanopore Diagnostic
• PerkinElmer Inc.
• Co-Diagnostic